TWO SIGMA SECURITIES, LLC
Broker-DealerPosition in ELAN — Elanco Animal Health Inc
CIK 1450144
NEW YORK, NY
Position in ELAN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$256,529
+$18,608 QoQ
Shares Held
10,720
-35.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Derivatives in ELAN
reported options exposure · as of Jun 30, 2024CallValue
$178,932
CallShares
12,400
PutValue
$324,675
PutShares
22,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $1,110,248 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
510 | $302,419 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
10,720 | $256,529 | |
| 3 | LQDA |
Liquidia Corp
|
5,496 | $207,419 | |
| 4 | CGC |
Canopy Growth Corp
|
99,372 | $94,304 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
18,770 | $77,895 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
27,909 | $76,470 | |
| 7 | SBFM |
Sunshine Biopharma Inc.
|
23,482 | $24,421 | |
| 8 | APUS |
Apimeds Pharmaceuticals US, Inc.
|
10,550 | $18,873 |
All Filings in ELAN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $256,529 | 10,720 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $324,675 | 22,500 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $237,921 | 16,488 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $178,932 | 12,400 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $426,536 | 26,200 | Call | Sole | 2024-05-15 | |
| 2023-09-30 | $229,296 | 20,400 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $370,208 | 36,800 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $248,482 | 24,700 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $148,209 | 15,767 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $235,940 | 25,100 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $592,200 | 63,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $337,272 | 27,600 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $221,182 | 18,100 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $585,268 | 47,161 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $496,400 | 40,000 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $631,669 | 50,900 | Call | Sole | 2022-11-14 | |
| 2020-03-31 | $238,028 | 10,631 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||